Artificial Intelligence (AI) in Drug Discovery Market | Size, Growth and Forecast 2025-2029
Artificial Intelligence (AI) in Drug Discovery Market | Size, Growth and Forecast 2025-2029
Publish Date: 2026-02-25 06:04:00
Source Domain: www.pharmiweb.com
-
Market Growth and Key Drivers: The global AI in drug discovery market is projected to grow by 25-30% over the next five years, driven by the demand to lower drug development costs and timelines, increased adoption of AI in healthcare and life sciences, advancements in computing power, and collaborations between pharmaceutical and AI firms.
-
Advancements and Efficiency Gains: AI in drug discovery leverages machine learning and deep learning to analyze large chemical datasets, predict molecular properties, optimize drug designs, and accelerate the drug development process. This significantly reduces research costs and development timelines.
-
Competitive Landscape: The AI in drug discovery market is highly competitive, with major players including Atomwise Inc., Exscientia, Insilico Medicine, and others, actively collaborating and innovating to drive market growth.
-
Regional Market Dynamics: North America is expected to be a key growth engine due to its strong pharmaceutical industry, advanced healthcare infrastructure, and funding. APAC is also growing due to an expanding pharmaceutical industry, healthcare investments, and government support for AI in healthcare.
-
Market Segmentation by Offering Types: The market is divided into software and services, with the software segment having the largest share due to its role in data analysis, drug design, and target identification. The services segment is growing rapidly due to increased demand for consulting, integration, and support.
-
Application Type Segments: AI is extensively used in oncology, infectious diseases, and other areas of drug discovery. Oncology, particularly, sees the most significant adoption due to the high prevalence of cancer and the need for effective treatments.
-
Growth Strategies: Companies employ organic and inorganic growth strategies, such as collaborations, acquisitions, and new product launches, to strengthen their market position and accelerate innovation in drug discovery.
